Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
87.50    0.00 (0.00%)
Bid:
85.00
Ask:
90.00
Spread: 5.00 (5.882%)
Market Cap: £5.75m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Trading Statement

27 Feb 2018 07:00

RNS Number : 9355F
Crimson Tide PLC
27 February 2018
 

CRIMSON TIDE PLC

("Crimson Tide" or "the Company")

TRADING AND STRATEGIC UPDATE

 

Crimson Tide, the provider of mpro5 Smart Mobility as a Service, is pleased to provide this trading update for the year ended 31 December 2017, and to bring the market up to date on its plans for continued expansion.

Financial

The Company had a very positive year in 2017. Revenue for the year ended December 31, 2017 is expected to total £2.3 million, an increase of approximately 23% on the previous year.

The Board's strategy is one of continued investment in the growth of the business and in particular the sales and marketing resources to ensure the Company is positioned to take full advantage of the opportunities that are emerging. Company headcount has doubled over 18 months, to address growth in demand for our products. Nothwithstanding the increased cost associated with this, profit before tax for 2017 is still expected to be similar to 2016 and has been achieved as a result of both revenue growth and increased gross margin.

Cash generation from organic business continues to be strong, and balances have been maintained notwithstanding a reduction of some £250k in debt on finance leases and funding investments in the Middle East, Northern Europe and the USA. The Company has no core debt and has approximately £750k in cash. 

Strategy and Outlook for 2018

From a strategic standpoint, the Company is launching its mpro5 Internet of Things (IOT) service during the current quarter. The Directors believe there is a clear opportunity to supply this new, sensor-based mpro5 module to existing, long-term, contracted clients. The market for cloud, mobility and IOT is undoubted and mpro5 provides clients with a fully inclusive service on a long-term, contracted, subscription basis.

In healthcare, the Company is making its first inroads into the NHS, where there is enormous scope for mpro5 to assist in areas from facilities management to patient care. The Company is recruiting a government-sector sales executive to pursue this opportunity as well as securing additional sales resources in the North of the UK and in Ireland.

The Directors believe that demand for mpro5 is stronger than at any previous time, as demonstrated by the number of opportunities in the pipeline, and that to maximise the benefits of this positive position, the Company should continue to invest in sales and marketing in 2018. It is anticipated that the percentage growth in topline revenue will be similar in 2018, then rise in the following two years. The Company strategy is to continue to expand in 2018 in order to facilitate the growth in the business and re-invest the increased cash generation into a larger operation whilst maintaining profit before tax at current levels in 2018.

Barrie Whipp, Executive Chairman of Crimson Tide, commented: "The Directors are very encouraged by our growth and believe that we should continue to pursue aggressively the opportunities we have developed. The Board has targeted growth at the top-line level while continuing to plough a proportion of profits back into the business. Our IOT module, combined with our geographic expansion, offers tremendous upside. We are also seeing traction in Northern Europe and the Middle East and I am confident that these opportunities will increase this year with both existing and new clients. The Directors are very optimistic for the future."

 

For further information:

Crimson Tide plcBarrie Whipp/Steve Goodwin01892 542 444

WH Ireland LimitedJames Joyce /James Bavister020 7220 1666

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEWFEMFASEFE
Date   Source Headline
15th Jun 202010:42 amRNSSignificant Contract Win
9th Jun 20204:06 pmRNSAnnual Report and Notice of AGM
7th May 20207:11 amRNSPreliminary Results
4th May 20204:05 pmRNSDIRECTOR RESIGNATION
1st Apr 20203:30 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSStatement regarding Coronavirus
13th Mar 20207:00 amRNSChange of Adviser
25th Feb 20208:19 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSSignificant contract wins in the rail sector
28th Jan 202010:43 amRNSHolding(s) in Company
3rd Jan 20209:17 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSSignificant long-term contract and trading update
1st Oct 20197:00 amRNSSignificant long-term contract win
27th Sep 20197:00 amRNSInterim Results
1st Jul 20197:00 amRNSDirector and Company Secretary Appointment
28th Jun 20193:02 pmRNSResult of AGM
27th Jun 20197:00 amRNSContract Wins and New Partnerships
7th Jun 20197:00 amRNSFinal Results and Notice of AGM
17th May 20197:00 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSPreliminary Announcement of Results to 31/12/18
16th Apr 20199:20 amRNSHolding(s) in Company
1st Mar 20192:56 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSContract Wins in the rail sector
29th Jan 20197:00 amRNSTrading Update
2nd Nov 20182:08 pmRNSExercise Of Options
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout
18th Nov 20169:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.